Portfolio

Investing in Startups That Will Shape the Future.

Investing in and celebrating ventures that shape the future.

Capacity Bio is developing a portfolio of small molecule mitophagy inducers.

Typewriter Therapeutics is developing an RNA-based gene writing therapeutic platform.

City Therapeutics is harnessing next-generation engineering of small interfering RNAs (siRNAs).

Imbria is developing novel therapies for patients with life-altering cardiometabolic disorders

PAhR Therapeutics is developing innovative treatments for Pulmonary Arterial Hypertension.

Crystalys Therapeutics is developing innovative therapies to transform the treatment of gout

Stealth Companies

Some portfolio companies are in stealth mode. Updates will be shared in due course.